Ferrari Shares Slide Following Debut of First Electric Model the Luce Critical Medicines Act Poised to Reshape Pharmaceutical Manufacturing and Supply Resilience in Europe Broad Market Gains as Healthcare and Tech Lead Communication Services Slips Recursion Pharmaceuticals Stock Tumbles to 52Week Low Amid Market Pressures Barclays Profit Climbs 18 on Strong Banking Income Raises FullYear Guidance NBCC Reports 388 YoY Profit Growth in Q4 Declares Dividend of 046 per Share BNZI Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges SPH Q1 2026 Earnings EPS Beats Estimates by 353 Stock Declines 16 Liberty Global LBTYK Q1 2026 Earnings Massive EPS Surprise Driven by NonOperating Gains Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges EEFT Q1 2026 Earnings EPS Beats Estimates by 666 Stock Gains 189 AMTD Q4 2020 Earnings EPS Surges Past Estimates Amid Strong Performance Gain Therapeutics GANX Edges Higher as Shares Approach Key Resistance Level Silvaco Group SVCO Pulls Back From Support A Potential Bottom or False Dawn Somnigroup International SGI Edges Lower Amid Quiet Trading Key Levels in Focus Commercial Vehicle Group Inc CVGI Surges 443 Support and Resistance Levels in Focus Laser Photonics Corporation LASE Surges 151 Tests Key Resistance at 10 Disneys Star Wars The Mandalorian and Grogu Opens with Lowest Thursday Previews in Franchise History STC Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Title Volume Ping An Biomedical Holds Steady Near Key Support as Consolidation Continues MAT Q1 2026 Earnings NarrowerthanExpected Loss Drives Modest Stock Uptick MBX Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Clinical Development Progress Northern Dynasty Minerals Ltd NAK Q3 2025 Earnings Small Positive EPS Surprise as Pebble Project Advances Ocular Therapeutix Q1 2026 Earnings EPS Misses Estimates as RD Investments Continue Prosperity Bancshares PB Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressure AIG Q1 2026 Earnings Strong Earnings Beat Amid Market Caution Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue